Table 1 Baseline characteristics for Kidney transplant recipients with and without infection
From: Infections in the first year of living related kidney transplantation in a young transplant cohort
Baseline characteristics | Total (n = 51) | Kidney transplant Recipient | OR (95%C.I) | p | |
|---|---|---|---|---|---|
With infection (n = 24) | Without infection ( n = 27) | ||||
Age (years) | |||||
Mean ± SD | 28.3 ± 10.3 | 26 ± 9.6 | 30.6 ± 10.8 | 0.955 | 0.122 |
Gender | |||||
Male | 28 (54.9%) | 13 (54.2%) | 15 (55.6%) | 0.945 (0.313 – 2.854) | 0.921 |
Female | 23 (45.1%) | 11 (45.8%) | 12 (44.4%) | ||
Aetiology of ESKD | |||||
Unknown | 19 (37.3%) | 6 (25.0%) | 13 (48.1%) | 0.359 (0.109 – 1.184) | 0.092 |
HTN | 8 (15.7%) | 2 (8.3%) | 6 (22.2%) | 0.318 (0.058 – 1.756) | 0.189 |
GN | 7 (13.7%) | 3 (12.5%) | 4 (14.8%) | 0.760 | |
SLE | 3(5.9%) | 3(12.5%) | 0 (0.0%) | – | – |
ADPKD | 2(3.9%) | 0(0%) | 2 (7.4%) | – | – |
VUR | 2(3.9%) | 2(8.3%) | 0 (0.0%) | – | – |
Alport | 1(2%) | 0(0%) | 1 (3.7%) | – | – |
DM type 1 | 1(2%) | 1(4.2%) | 0 (0.0%) | – | – |
Preeclampsia | 1(2%) | 1(4.2%) | 0 (0.0%) | – | – |
Amyloidosis | 1(4.2%) | 0 (0.0%) | 0 (0.0%) | – | – |
CIN | 2(3.9%) | 2(8.3%) | 0 (0.0%) | – | – |
ATG | 43(84.3%) | 20(83.3%) | 23 (85.2%) | 0.870 (0.192 – 3.936) | 0.856 |
Tacrolimus Level | |||||
Mean ± SD | 8.8 ± 3.1 | 8.2 ± 3.9 | 9.30 ± 2.0 | 0.882 (0.722 – 1.077) | 0.217 |
Median (Min. – Max.) | 8.8(1.4 – 19.9) | 7.8(1.4 – 19.9) | 8.95 (6.50 – 13.8) | ||
MMF | 48(94.1%) | 22(91.7%) | 26(96.3%) | 0.423 (0.036 – 4.985) | 0.494 |
Donor > 60 years | 9(17.6%) | 6(25%) | 3 (11.1%) | 2.667 (0.586 – 12.128) | 0.204 |
Slow graft function | 1(2%) | 0(0%) | 1 (3.7%) | – | – |
PTDM | 10(19.6%) | 6(25%) | 4 (14.8%) | 1.917 (0.469 – 7.831) | 0.365 |
Haemoglobin | |||||
Mean ± SD | 10.4 ± 1.7 | 10.1 ± 1.7 | 10.7 ± 1.7 | 0.779 (0.550 – 1.104) | 0.160 |
Median (Min. – Max.) | 10.3(7.3 – 15.3) | 10.2(7.8 – 14) | 10.8(7.3 – 15.3) | ||
Preemptive Tx | 21(41.2%) | 5(20.8%) | 16(59.3%) | 0.181 (0.052 – 0.631) | 0.007 |